Drug intelligence / Profile preview

DOTAP

Development stage
Preclinical
Lead developer
Avanti Research
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
In Vitro (cell Culture, Transfection Medium), In Vivo (experimental Injection, Often Intravenous)
01

Overview

DOTAP is a **synthetic cationic lipid**—specifically, 1,2-dioleoyl-3-trimethylammonium propane—used predominantly as a **liposomal transfection agent** for delivering DNA, RNA, and other negatively charged molecules to eukaryotic cells in vitro and in vivo[1][4][5][6][7][9]. DOTAP features a quaternary ammonium headgroup linked to two oleic acid tails via ester bonds, producing a permanent positive charge that interacts with nucleic acids and cell membranes[2][4][7]. DOTAP forms stable cationic liposomes or bicelles, efficiently encapsulating and protecting nucleic acids, enabling their uptake through electrostatic interactions and multiple cellular pathways, including clathrin- and caveolin-mediated endocytosis[9]. (R)-DOTAP and (S)-DOTAP are enantiomers with differing biological activities; (R)-DOTAP may produce stronger immunological responses, especially in cancer vaccine models[2]. Commonly used in gene therapy research, DOTAP is chemically available as different salt forms (chloride, methyl sulfate), and as liposomal formulations for transfection, functioning with high efficiency even in serum and suitable for gene knockdown, mRNA, siRNA, and plasmid delivery[3][6]. DOTAP’s primary use is research; it is not an approved pharmaceutical drug.

Brand names
DOTAP Transfection ReagentTRANSFASTTFX REAGENTS TRANSFECTION TRIO
Other names
1,2-Dioleoyl-3-trimethylammonium propaneDOTAP chlorideDOTAP methyl sulfateDOTAP MS1,2-Dioleoyloxy-3-(trimethylammonium)propaneN-[1-(2,3-Dioleoyloxy)propyl]-N,N,N-trimethylammonium methyl-sulfateMR86K0XRQPMR-86K0XRQPMR 86K0XRQP

Beyond the preview

Go deeper on DOTAP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DOTAP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call